Atlas Trials

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT05292027 · COMPLETED

Trial details

NCT number
NCT05292027
Sponsor
Sichuan Cancer Hospital and Research Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2022-03-26
Primary completion
2022-11-18
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.